Search clinical trials for: SARS-CoV-2 diagnostic rapid test

Total 643 results

European Institute of Oncology
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Azienda Ospedaliera... and other collaborators

Completed

Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV (I-GLOBAL)

COVID

Italy
PT Bio Farma
Center for Child Health Universitas Gadjah Mada (CCH-PRO UGM; Cipto Mangunkusumo... and other collaborators

Recruiting

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

Vaccine Adverse Reaction | Vaccine Reaction

Indonesia
The University of Hong Kong
Immuno Cure 3 Limited

Recruiting

A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19

Covid19

Hong Kong
Argorna Pharmaceuticals Co., LTD

Completed

Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster

SARS-CoV-2

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Baylor Research Institute

Unknown

Study Testing Convalescent Plasma vs Best Supportive Care

Pneumonia, Interstitial
Institute of Medical Biology, Chinese Academy of...
West China Second University Hospital; Yunnan Center for Disease Control and...

Completed

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

COVID-19

China
Novavax

Completed

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

COVID-19

United States
Sunnybrook Health Sciences Centre
University Health Network, Toronto; Unity Health Toronto; Scarborough General... and other collaborators

Terminated

COVID-19 Vaccine Boosters in Patients With CKD (BOOST KIDNEY)

COVID-19 | Chronic Kidney Diseases

Canada
PT. Kimia Farma (Persero) Tbk

Recruiting

Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

COVID-19

Indonesia
Caja Costarricense de Seguro Social
Universidad de Costa Rica; Ministry of Health Costa Rica

Recruiting

Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients (SECR-02)

Covid19

Costa Rica
Vanderbilt University Medical Center
National Center for Advancing Translational Sciences (NCATS); Dolly Parton

Completed

Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults (PassItOn)

COVID-19 | SARS-CoV-2 | Coronavirus

United States
Pontificia Universidad Catolica de Chile
Sinovac Biotech Co., Ltd; Ministry of Health, Chile

Active, not recruiting

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (CoronaVac3CL)

Covid19 | Vaccines

Chile
Université de Sherbrooke
University of Manitoba; University of Toronto

Completed

Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes Mellitus (SoL)

Diabetes, Gestational

Canada
University of Maryland, Baltimore

Completed

COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2

COVID-19 | SARS-CoV2 Infection

United States
Centre Hospitalier Intercommunal Creteil
University Hospital, Paris; Hôpital Necker-Enfants Malades; Groupe Hospitalier... and other collaborators

Recruiting

Diagnostic Accuracy of Rapid Molecular Tests for Group A Streptococcal Pharyngitis Using Saliva Samples

Streptococcal Pharyngitis

France
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III (COVID-19)

COVID-19 Pandemic

Philippines, Indonesia, Russian Federation
Stemirna Therapeutics

Recruiting

New Generation mRNA Booster Vaccine Against Emerging VOCs

Efficacy | Safety | Immunogenicity

Lao People's Democratic Republic
Instituto Grifols, S.A.

Completed

A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)

COVID-19

Spain
University of Minnesota
National Institutes of Health (NIH); National Center for Research Resources... and other collaborators

Completed

Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia

Dystonia, Focal, Task-specific

United States
University of Campania "Luigi Vanvitelli"

Completed

The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution

Non-Alcoholic Fatty Liver Disease

Italy
Pontificia Universidad Catolica de Chile

Completed

Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant

COVID-19 | SARS-CoV-2 Infection | Solid Organ Transplant | Vaccine Response Impaired

Chile
Andalusian Network for Design and Translation of...

Completed

Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

SARS-CoV 2

Spain
University Hospital, Caen

Completed

Transverse Myelitis Related to SARS-CoV-2 Vaccines

Vaccine Adverse Reaction

France
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

SARS-CoV-2 | Prevention

China
Foundation for Innovative New Diagnostics, Switzerland
Institute of Tropical Medicine, Belgium; Nigerian Institute of Medical Research and other collaborators

Completed

Evaluation Study of RDTs Detecting Antibodies Against HCV

Hepatitis C

Belgium, Georgia, Nigeria
University of Alabama at Birmingham
ViraCor Laboratories

Withdrawn

COVID Vaccine Immunity in Kidney Transplant Recipients

End Stage Renal Disease | Kidney Transplant; Complications
Cinnagen
Vaxine Pty Ltd

Completed

Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years

COVID-19

Iran, Islamic Republic of
ACM Biolabs

Completed

Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

SARS-CoV-2 Infection

Australia
Novavax

Active, not recruiting

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19

United States
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

COVID-19

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Not yet recruiting

A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

SARS-CoV-2
University of Melbourne
Southern Star Research Pty Ltd.

Completed

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

SARS-CoV-2

Australia
Livzon Pharmaceutical Group Inc.

Completed

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study (COVID-19)

COVID-19 Pandemic

Malaysia, Pakistan
AusDiagnostics Pty Ltd.

Not yet recruiting

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Respiratory Viral Infection
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...

Completed

Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence

SARS CoV 2 Infection

Mexico
University of Milano Bicocca

Completed

Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases (ThalaCoV)

Covid19 | Thalassemia Major

Italy
Livzon Pharmaceutical Group Inc.

Active, not recruiting

The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine (Omicron)

COVID-19 Pandemic

China
Centre Georges Francois Leclerc

Not yet recruiting

Use of an Ultra-rapid BRCA1/2 Status Screening Test in Theranostic Indication: Performance and Interest for Patients and Practitioners (TURBO)

Breast Cancer
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19 | SARS CoV 2 Infection

Australia
Sinovac Research and Development Co., Ltd.

Completed

Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults

Covid19

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

COVID-19

China
Centre de Recherches et d'Etude sur la Pathologie...

Completed

COVID-19 and HIV Patients (COCOVIH)

Covid19

France
Agencia Costarricense de Investigaciones Biomedicas
Caja Costarricense de Seguro Social; Fundación INCIENSA (FUNIN); Ministerio de... and other collaborators

Unknown

Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica (RESPIRA)

COVID-19
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
Universidad Peruana Cayetano Heredia
National University of San Marcos, Peru

Completed

Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru (Covid-Peru)

COVID-19

Peru
Max O'Donnell
New York Blood Center; Amazon.com, Inc.

Completed

Plasma Therapy of COVID-19 in Severely Ill Patients

SARS-CoV-2 Infection

United States, Brazil
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
Institute of Medical Biology, Chinese Academy of...
West China Second University Hospital; Yunnan Center for Disease Control and...

Completed

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years

COVID-19

China
Central Hospital, Nancy, France

Completed

SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

COVID-19 Infection

France

Search clinical trials for: SARS-CoV-2 diagnostic rapid test

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations